Global health security isn’t theoretical. It’s the frontline defense between outbreaks and containment. But fragile surveillance systems, underfunded labs, and siloed response plans remain persistent threats. ClineEpi Partners has worked with ministries of health to evaluate Global Health Security Agenda (GHSA) capacities using adapted Joint External Evaluation frameworks. Through this work, we’ve observed common challenges:…
Pharmaceutical success no longer ends with approval. Post-market evidence now shapes formulary decisions, safety monitoring, and even label expansion. RWE provides insights from the real world—outside the trial bubble. At ClineEpi Partners, we support clients through the design and execution of RWE studies that align with regulatory, payer, and clinical expectations. From retrospective cohort analyses…